Margot Zöller spends much of her time researching CD44, Cell biology, Cancer research, Immunology and Microvesicles. Her work carried out in the field of CD44 brings together such families of science as Molecular biology, Metastasis, Extracellular matrix, Antibody and Gene isoform. She has included themes like T cell and CD151 in her Cell biology study.
Her Angiogenesis study in the realm of Cancer research connects with subjects such as Oxidoreductase complex. Her Immunology research is multidisciplinary, incorporating elements of Lamina propria and Cancer stem cell. Her research integrates issues of Fibronectin, Cell culture and Tetraspanin in her study of Microvesicles.
Her primary scientific interests are in Immunology, Cancer research, CD44, Cell biology and Molecular biology. Her Immunology study frequently involves adjacent topics like Cytotoxic T cell. Her biological study spans a wide range of topics, including Tumor progression, Metastasis, Pancreatic cancer and Bone marrow.
Her work in CD44 addresses issues such as Pathology, which are connected to fields such as Colorectal cancer. She combines subjects such as Microvesicles, Tetraspanin and Cell adhesion with her study of Cell biology. Her research investigates the connection between Molecular biology and topics such as In vivo that intersect with issues in In vitro.
Cancer research, Microvesicles, Cell biology, Exosome and Metastasis are her primary areas of study. Her Cancer research research is multidisciplinary, relying on both Cancer, Cancer stem cell, Tumor progression, Integrin and Bone marrow. Her Microvesicles research includes elements of Stromal cell, Angiogenesis, Wound healing, Immunology and Tetraspanin.
Her Cell biology study integrates concerns from other disciplines, such as Cell, CD44 and Transcription factor. Her CD44 research integrates issues from Ex vivo, Fibronectin, Cell adhesion, Cell adhesion molecule and Leukemia. Her study focuses on the intersection of Exosome and fields such as Pancreatic cancer with connections in the field of Pathology.
Her primary areas of investigation include Microvesicles, Cancer research, Exosome, Immunology and Cell biology. Her Microvesicles research incorporates elements of Stromal cell, CD44, Oncology, Cell adhesion and Cell adhesion molecule. The concepts of her CD44 study are interwoven with issues in Wound healing and Fibronectin, Extracellular matrix.
Her Cancer research study combines topics in areas such as Cell, CXCR4, CD151, Metastasis and Motility. Her studies in Exosome integrate themes in fields like TSPAN8, Internal medicine, Flow cytometry and Paca. The study incorporates disciplines such as Cancer stem cell and Angiogenesis in addition to Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A NEW VARIANT OF GLYCOPROTEIN CD44 CONFERS METASTATIC POTENTIAL TO RAT CARCINOMA CELLS
U. Günthert;M. Hofmann;W. Rudy;S. Reber.
Cell (1991)
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Margot Zöller.
Nature Reviews Cancer (2011)
Tetraspanins: push and pull in suppressing and promoting metastasis
Margot Zöller.
Nature Reviews Cancer (2009)
Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation.
Irina Nazarenko;Sanyukta Rana;Alexandra Baumann;Jessica McAlear.
Cancer Research (2010)
Toward tailored exosomes: The exosomal tetraspanin web contributes to target cell selection
Sanyukta Rana;Shijing Yue;Daniela Stadel;Margot Zöller;Margot Zöller.
The International Journal of Biochemistry & Cell Biology (2012)
CD44 in cancer progression: adhesion, migration and growth regulation.
R Marhaba;M Zöller;M Zöller.
Journal of Molecular Histology (2003)
Participation in normal immune responses of a metastasis-inducing splice variant of CD44
Robert Arch;Karin Wirth;Martin Hofmann;Helmut Ponta.
Science (1992)
Prevention of tumor metastasis formation by anti-variant CD44.
S Seiter;R Arch;S Reber;D Komitowski.
Journal of Experimental Medicine (1993)
CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines.
Martin Hofmann;Wolfgang Rudy;Margot Zöller;Cornelia Tölg.
Cancer Research (1991)
Exosomal tumor microRNA modulates premetastatic organ cells.
Sanyukta Rana;Kamilla Malinowska;Margot Zöller;Margot Zöller.
Neoplasia (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Ben-Gurion University of the Negev
University Hospital Heidelberg
German Cancer Research Center
Karlsruhe Institute of Technology
Leibniz Association
University of Ulm
TU Dresden
Vanderbilt University
Weizmann Institute of Science
University of Amsterdam
University of Helsinki
University of Alberta
Virginia Tech
National Institute of Standards and Technology
University of Edinburgh
British Antarctic Survey
Virginia Tech
CSIRO Marine and Atmospheric Research
University of Giessen
Northwestern University
Johnson & Johnson
University of Rome Tor Vergata
University of New Mexico
Robert Bosch (Germany)
Ruhr University Bochum
National Institutes of Health